Otonomy to Present at Two Upcoming Investor Conferences
February 24 2020 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that David A. Weber, Ph.D., president
and chief executive officer, is scheduled to present at two
upcoming investor conferences:
- Cowen 40th Annual Health Care Conference in Boston on March 2,
2020 at 12 p.m. ET (9 a.m. PT)
- Oppenheimer 30th Annual Healthcare Conference in New York on
March 17, 2020 at 1 p.m. ET (10 a.m. PT)
A live audio webcast of the presentations will be available
through the Events page of the company's website
(www.otonomy.com).
About Otonomy Otonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs including Ménière’s disease, hearing loss, and
tinnitus. For additional information please visit
www.otonomy.com.
Contacts:
Media Inquiries:Spectrum ScienceChloé-Anne RamseyVice
President404.865.3601 cramsey@spectrumscience.com
Investor Inquiries:Westwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From May 2024 to Jun 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2023 to Jun 2024